News

Medical Dialogues35m
Oveporexton Boosts Wakefulness and Cuts Cataplexy in Narcolepsy Type 1, Phase 2 Trial Finds
France: A new phase 2 clinical trial published in The New England Journal of Medicine has shown that oveporexton (TAK-861), ...
Medical Dialogues49m
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...